National Cheng Kung University Hospital

Institution (Healthcare)

Homepage ROR

Also Known As

NCKU Hospital, National Cheng Kung University Hospital

13.5K

Publications

647.7K

Citations

1.8K

Authors

1.7K

Concepts

About

National Cheng Kung University Hospital is a healthcare institution in Tainan City, Taiwan known for medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	64	944	44.2K
2	Engineering	47	398	15.3K
3	Education	25	76	7.8K
4	Arts	9	18	605
5	Business	6	7	253

National Cheng Kung University Hospital

13.5K

Publications

647.7K

Citations

Page 1

	Year	Citations
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia Liang‐Kung Chen, Li-Kuo Liu, Jean Woo, Journal of the American Medical Directors Association East Asian StudiesGlobal HealthInternational HealthConsensus ReportSarcopenic Obesity	2014	4.2K
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial Yoon‐Koo Kang, Narikazu Boku, Taroh Satoh, The Lancet Esophageal CancerGastrointestinal OncologyLeast TwoMedicineGastroenterology	2017	2.2K
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer Pasi A. Jänne, James Chih‐Hsin Yang, Dong‐Wan Kim, New England Journal of Medicine	2015	2.1K
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen, The Lancet Oncology OncologyHepatologyα-Fetoprotein ConcentrationsClinical TrialsPathology	2019	1.6K
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials James Chih‐Hsin Yang, Yi‐Long Wu, Martin Schüler, The Lancet Oncology Lux-lung 3Lux-lung 6MedicinePathologyBronchial Neoplasm	2015	1.6K
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B Patrick Marcellin, Ting‐Tsung Chang, Seng Gee Lim, New England Journal of Medicine	2003	1.3K
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial José Baselga, Ian Bradbury, Holger Eidtmann, The Lancet Breast OncologyOncologyPathologyBreast CancerCancer Treatment	2012	1.3K
Validation of the national health insurance research database with ischemic stroke cases in Taiwan Ching‐Lan Cheng, Yea‐Huei Kao Yang, Swu‐Jane Lin, Pharmacoepidemiology and Drug Safety	2010	1.3K
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky, The Lancet NanomedicineOncologyPancreatic CancerMedicineFolinic Acid	2015	1.2K
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote, New England Journal of Medicine	2003	996

Page 1